The B Lymphocyte Differentiation Factor (BAFF) Is Expressed in the Airways of Children with CF and in Lungs of Mice Infected with Pseudomonas aeruginosa
Authors:
- Daniel R. NeillDNDaniel R. Neill
- Gemma L. SaintGSGemma L. Saint
- Joanne L. FothergillJFJoanne L. Fothergill
- Craig WinstanleyCWCraig Winstanley
- Stephen E. ChristmasSCStephen E. Christmas
- Joseph R. SlupskyJSJoseph R. Slupsky
- Paul S. McNamaraPMPaul S. McNamara
- Aras KadiogluAKAras Kadioglu
- Brian F. FlanaganBFBrian F. Flanagan
Open Access
- 21 May 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e95892
Abstract
Chronic lung infection with Pseudomonas aeruginosa remains a major cause of mortality and morbidity among individuals with CF. Expression of mediators promoting recruitment and differentiation of B cells, or supporting antibody production is poorly understood yet could be key to controlling infection. BAFF was measured in BAL from children with CF, both with and without P. aeruginosa, and controls. Mice were intra-nasally infected with P. aeruginosa strain LESB65 for up to 7 days. Cellular infiltration and expression of B cell chemoattractants and B cell differentiation factor, BAFF were measured in lung tissue. BAFF expression was elevated in both P. aeruginosa negative and positive CF patients and in P. aeruginosa infected mice post infection. Expression of the B cell chemoattractants CXCL13, CCL19 and CCL21 increased progressively post infection. In a mouse model, infection with P. aeruginosa was associated with elevated expression of BAFF and other B cell chemoattractants suggesting a role for airway B cell recruitment and differentiation in the local adaptive immune response to P. aeruginosa. The paediatric CF airway, irrespective of pseudomonal infection, was found to be associated with an elevated level of BAFF implying that BAFF expression is not specific to pseudomonas infection and may be a feature of the CF airway. Despite the observed presence of a potent B cell activator, chronic colonisation is common suggesting that this response is ineffective.Keywords
This publication has 23 references indexed in Scilit:
- Induction of Type I Interferon Signaling by Pseudomonas aeruginosa Is Diminished in Cystic Fibrosis Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity against Pseudomonas aeruginosa Acute Lung InfectionInfection and Immunity, 2011
- A Subtype of aPseudomonas aeruginosaCystic Fibrosis Epidemic Strain Exhibits Enhanced Virulence in a Murine Model of Acute Respiratory InfectionThe Journal of Infectious Diseases, 2010
- Pseudomonas aeruginosa: Host defence in lung diseasesRespirology, 2010
- CCR7 Deficiency Leads to Leukocyte Activation and Increased Clearance in Response to Pulmonary Pseudomonas aeruginosa InfectionInfection and Immunity, 2010
- Expression of B-Cell Activating Factor Enhances Protective Immunity of a Vaccine againstPseudomonas aeruginosaInfection and Immunity, 2009
- Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenzaProceedings of the National Academy of Sciences, 2007
- Airway Epithelial Cells Produce B Cell-Activating Factor of TNF Family by an IFN-β-Dependent MechanismThe Journal of Immunology, 2006
- Chemokine control of lymphocyte trafficking: a general overviewImmunology, 2005
- Recombinant OprF–OprI as a vaccine against Pseudomonas aeruginosa infectionsVaccine, 2004